glp-1 sleep apnea trial Efficacy of Receptor agonists in treating Obstructive apnea: A systematic review and meta-analysis of cardiometabolic and respiratory outcomes Sleep apnea: Zepbound, Mounjaro improves

Research from the National Library of Medicine supports that telogen effluvium can occur after significant physical changes, including weight fluctuations

In 2025, the RAND American Life Panel showed that women aged 3049 were more than twice as likely as men of a similar age to report current or past use of GLP-1s

Food and Drug Administration (FDA) for obesity management, have shown efficacy not only in weight reduction but also in improving metabolic 10,11,12,13,14,15 and cardiovascular outcomes 16

These advances again produce better long-term glycemic control and stable metabolic results, reinforcing their clinical value

Moreover, because these drugs are already approved for other uses, such as diabetes and weight management, they may be a safer and faster alternative to developing entirely new addiction treatments